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Dedication ((optional)) 
Abstract: The multicomponent 1,3-dipolar cycloaddition of different 
1,2-diaza-1,3-dienes with in situ-generated azomethine ylides 
produces 1,2,4-triazepines or pyrrolidines by means of [3+4] or [3+2] 
cycloadditions, respectively. The regioselectivity is controlled by the 
electron-withdrawing group bound to the azo-moiety of the 1,2-
diaza-1,3-diene which promotes exclusively the [3+4] cycloaddition. 
When the electron-withdrawing group is replaced with a phenyl 
group only a [3+2] cycloaddition occurs. 
Introduction 
1,3-Dipolar cycloaddition[ 1 ] (1,3-DC) is a fascinating 
stereocontrolled reaction where a 1,3-dipole and an alkene, 
allene, or alkyne react to give a five-membered heterocyclic ring 
allowing the presence of large series of functional groups.[ 2 ] 
These multicomponent,[3] atom economy,[4] catalyzed[5]1,3-DCs 
constitute a clear trend of innovation in both laboratory and 
industrial scale, cycloadditions being the most frequently 
employed.[ 6 ] Some of us used this methodology in several 
multicomponent 1,3-DCs of diethyl aminomalonate or α-amino 
esters with 2-oxoaldehydes and dipolarophiles.[ 7 , 8 , 9 ] At this 
moment, the cycloaddition between azomethine ylides and 
electrophilic alkenes is the most frequently reported version due 
to its high regio- and diastereoselection.[10] The azomethine ylide, 
which can be generated in situ through several manners, reacts 
efficiently with maleimides, maleates and their derivatives, 
fumarates, acrylic systems, vinylic sulfones, nitroalkenes, 
enones, inones, etc.[11] The main trend of all these acceptors is 
that a carbon-carbon double or triple bond are involved in the 
pericyclic transformation affording the corresponding [3+2] 
cycloaddition product. However, it has been reported that some 
examples with particular alkenes did not follow the general [3+2] 
pattern. For example, a [3+3] cycloaddition was observed in self-
cyclizations of azomethine ylides derived from isatin with various 
primary or cyclic secondary amines,[ 12 ] with quinone 
monoimides,[ 13] or using phthalazinium dicyanomethanides.[ 14 ] 
[3+6] Cycloadditions were detected employing 2-
acylcycloheptatrienes,[ 15 ] fulvenes,[ 16 ] or tropone,[ 17 ] and also 
1,7-electrocyclizations have been published.[ 18 , 19 ] In addition, 
highly functionalized 1,2,4,5-tetrazepine derivatives have been 
obtained via unprecedented [4+3] cycloaddition of in situ 
generated azoalkenes with C,N-cyclic azomethine imine.[ 20 ] 
However, [4+3] cycloaddition processes involving azomethine 
ylides have not been reported yet. 
Looking for an expansion of the scope of this 1,3-DC, 1,2-
diaza-1,3-dienes (DDs) 1 (Scheme 1) were envisaged as 
dipolarophile candidates. The chemical properties of DDs are 
based on to the electron-withdrawing effect of the azo group in 
the heterodiene system. DDs 1 present an umpolung[21] of the 
traditional carbonyl reactivity.[22] This nature makes these neutral 
compounds enable to nucleophilic additions at the terminal 
carbon atom of the azo-ene system. Thus, the reactivity of DDs 
1 remains opposite with respect to the natural polarity of the 
known carbonyl derivatives, and their employment opens the 
possibility to have a carbon atom in the α-position to the 
carbonyl group with a reverse of the normal polarity. Besides, 
the substituents of this system play an important role, and 
electron-withdrawing groups on the terminal carbon or nitrogen 
atom enhance the stability and the electrophilic character of the 
heterodiene system.[ 23 ] DDs 1 are important synthetic 
intermediates and versatile building blocks in the construction of 
a large number of heterocycles.[ 24 ] They are good Michael 
acceptors in 1,4-addition reactions[25] and can react as dienes in 
inverse electron-demand [4+2] cycloadditions to give 
tetrahydropyridazines.[ 26] DDs 1 have been also submitted to 
1,3-DC in combination with nitrones to afford both 3-substituted-
5-diazenyl isoxazolidines,[ 27 ] and 2,3,4,7-tetrahydro-1,2,4,5-
oxatriazepine.[28] 
To the best of our knowledge, DDs have not been used as 
dipolarophiles with azomethine ylides generated by thermal 
decarboxylation of 2, so in this work the reactivity of several 
azomethine ylides with these azo-ene derivatives will be 
surveyed. On the basis of the substituents on the 1,2-diaza-1,3-
dienes a diversity-oriented synthesis (DOS)[29] can be designed 
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according to the different skeleton that would be achieved 
(Scheme 1). So, this divergent synthesis would afford through a 
[3+2] cycloaddition pyrrolidines 5, which are demonstrated to be 
biologically active compounds and very interesting building 
blocks in synthetic organic chemistry.[ 30 ] The same reaction 
would furnish also 1,2,4-triazepines 4 through a [3+4] 
cycloaddition that are not so common in the literature as their 
preparation is difficult.[ 31 ] They belong to the family of 
triazepines[ 32 ] which are very attractive, both from the 
pharmacological and chemical points of view. Recently, 1,2,4-
triazepines E were prepared by 1,3-DC of C-N-cyclic 
azomethine imines C and aza-o-quinonedimethanes D which 
provided the 1,2-dinitrogen component.[33] In our work, the 1,2-
dinitrogenated fragment would be incorporated by DDs 1 
employing azomethine ylides as 1,3-dipoles instead. 
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Scheme 1. Diversity-oriented synthesis of triazepines 4 or pyrrolidines 5 
starting from DDs 1 and azomethine ylides 2. Comparison of triazepine’s 
assembly pathways by means of 1,3-dipolar cycloadditions. 
Results and Discussion 
Based on our experience we decided to develop a conventional 
thermal multicomponent 1,3-DC using azomethine ylides and 
1,2-diaza-1,3-dienes 1 as dipolarophiles.  
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Scheme 2. Multicomponent 1,3-DC between DD 1a, sarcosine 2a, and 
paraformaldehyde 3a. 
For the optimization of the process we employed as model DD 
1a,[34] sarcosine 2a as N-alkylated amino acid and 
paraformaldehyde 3a (Scheme 2). While the reaction at room 
temperature and at 70 °C didn’t work, by increasing the reaction 
temperature until the boiling point of toluene, the TLC analysis of 
the reaction revelead the formation of a new product that was 
isolated by flash chromatography. Initially, we expected the 
formation of pyrrolidine 4’a, but, with our surprise, the NMR 
spectrum of the isolated product clearly indicates that 1,2,4-
triazepine 4a was achieved in 58% yield. In fact, the signals in 
the NMR carbon spectrum at 158.9, 170.9, and 174.8 ppm, 
respectively indicate the presence of an hydrazone moiety 
toghether with two ester functions, in agreement with the 
structure of 1,2,4-triazepine 4a. The reaction was performed 
also in a microwave reactor at 100 ºC for 2 h obtaining very low 
conversions (< 10%) and some decomposition products. An 
increment of the yield (65%) was achieved by adding two equiv 
of aldehyde 3a and also two equivalents of the DD 1a.  
 Under these optimal reaction conditions (Sheme 2), we 
next examined the reactivity of different N-alkylated amino acids 
and aldehydes. Unfortunately, the incorporation of other 
aldehydes such as cinnamaldehyde, ethyl glyoxylate, 2,2-
dimethoxyacetaldehyde, crotonaldehyde, pentanal and 
benzaldehyde in the reaction of DD 1a and sarcosine 2a was 
unfruitful, even heating the reaction mixture at 140 ºC in a 
pressure tube. Also when N-methylalanine was allowed to react 
with paraformaldehyde and DD 1a, no reaction product was 
detected by 1H NMR spectroscopy of the crude product. The 
scope of the reaction was next evaluated in the reaction of 
sarcosine 2a with paraformaldehyde 3a and different DDs 1a-f. 
1,2.4-Triazepines 4a-f were obtained moderate to good yield 
(30-65%) (Scheme 3).  
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Scheme 3. Substrate scope of different DDs 1a-f in the reaction with 
sarcosine 2a, and paraformaldehyde 3a. Reaction conditions: DD 1a (1.0 
mmol), sarcosine 2a (0.5 mmol), paraformaldehyde 3a (1.0 mmol), toluene 
(5.0 mL), reflux. 
 
A plausible mechanism for this [4+3] cycloaddition is described 
in Scheme 4. Initially, the azomethine ylide G is generated by a 
thermal decarboxylation of the iminium intermediate F. Then, 
assuming that a more or less stepwise mechanism takes place, 
a Michael addition of the azomethine ylides G to the terminal 
carbon atom of the azo-ene system of DDs 1a-f generates the 
hydrazone anion intermediates H. The subsequent N-
intramolecular nucleophilic attack on the iminium moiety 
furnishes the final 1,2.4-triazepines 4a-f. 
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Scheme 4. Plausible mechanism for the multicomponent 1,3-DC between 
DDs 1a-f, sarcosine 2a, and paraformaldehyde 3a. 
 
The presence of an electron-withdrawing group on to the 
terminal nitrogen of the azo-ene system (CO2R1) in N-EWG-DDs 
1a-f seems to be crucial for the reaction course, as it stabilizes 
the intermediate H. Aware of this possibility, we have tested the 
reaction of sarcosine 2a, paraformaldehyde 3a and N-phenyl-
DDs 1g,h bearing a non-withdrawing substituent like a phenyl 
group at the nitrogen in position 1 of the azo-ene system, under 
the same conditions previously employed.  
With our delight, we have noted that this simple change in the 
structure of the DDs 1 produces a different reaction pattern, 
affording a conventional [3+2] dipolar cycloaddition (Scheme 5). 
In these cases, N-phenyl-DDs 1g and 1h afforded the 
corresponding 4-(phenyldiazenyl)pyrrolidine-3-carboxylates 5a 
and 5b in 60 and 39% yields, respectively. The signals of NMR 
carbon spectra have been diagnostic to reveal the structure of 
compounds 5. The signal of a quaternary carbon at around 80.0 
ppm and the lack of the hydrazone moiety confirm the formation 
of the pyrrolidinic core. The relative configuration was 
unambiguously confirmed by nOe experiments, detecting a 
negative nOe between methyl group and Ha, but a large positive 
one between both methyl groups in molecule 5a. This 
stereochemical outcome derives from the high sterospecificity of 
the 1,3-DC which justify a concerted process at this temperature. 
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Scheme 5. [3+2] Dipolar cycloaddition of N-phenyl-DDs 1g,h in the reaction 
with sarcosine 2a, and paraformaldehyde 3a. Reaction conditions: DDs 1g,h 
(1.0 mmol), sarcosine 2a (0.5 mmol), paraformaldehyde 3a (1.0 mmol), 
toluene (5.0 mL), reflux. 
 
The different behavior observed in the 1,3-DC reaction of N-
phenyl-DDs 1g-h, encouraged us to incorporate other aldehydes 
such as ethyl glyoxylate, benzaldehyde. While all these attempts 
carried out with the aldehydes were unfruitful, the reaction 
between N-phenyl-DDs 1g,h, N-alkylated amino esters such as 
N-benzyl glycine ethyl ester 6a or ethyl pipecolinate 6b and 
paraformaldehyde 3a in toluene under reflux furnished the 
corresponding 1-benzyl 3-(phenyldiazenyl)pyrrolidine-2,4-
dicarboxylates 7a,b and 1-(phenyldiazenyl)octahydroindolizine-
2,8a-dicarboxylates 7c,d. (Scheme 6). In these latter cases, the 
generation of azomethine ylide occurs through a [1,2]-prototropy 
shift after the formation of the iminium salt with 
paraformaldehyde 3a. 
The structure of 7a-d was confirmed by NMR methods: the 
absence of signals due to hydrazone moiety in 13C NMR, and 
quaternary carbons at around 80 ppm indicates that [3+2] 
dipolar cycloaddition occurred. Again, nOe experiments of 
compound 7c revealed the cis-arrangement of both esters and 
methyl groups. With respect to the regioselectivity of the attack 
of the negative charge of the dipole, starting from N-EWG-DDs 
1a-f, the addition occurred with the opposite trend observed for 
the reactions involving N-phenyl-DDs 1g,h (Scheme 7). In the 
case of 1-benzyl 3-(phenyldiazenyl)pyrrolidine-2,4-dicarboxylate 
7a, the singlet signal of one hydrogen in 1H-NMR at 4.58 ppm 
excludes the regioisomer 7a’. For compound 7c, the structure of 
the regioisomer obtained is confirmed by the ABX coupling 
pattern occurring between a methyne and a methylene group. 
The assignments were further confirmed by 1H-1H COSY 
spectrum. 
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Scheme 6. [3+2] Dipolar cycloaddition of N-phenyl-DDs 1g,h, 
paraformaldehyde 3a, and glycine ethyl ester 6a or ethyl pipecolinate 6b.[a] 
 [a] Reaction conditions: N-phenyl-DDs 1g,h (1.0 mmol), N-alkylated amino 
esters 6a,b (0.5 mmol), paraformaldehyde 3a (1.0 mmol), toluene (5.0 mL), 
reflux. 
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Scheme 7. Possible regioisomers of 1-benzyl (phenyldiazenyl)pyrrolidine-
dicarboxylate 7a,7a’ and (phenyldiazenyl)octahydroindolizine-dicarboxylate 7c, 
7c’. 
 
A very important detail of this divergent synthesis was the 
influence of the terminal substituent in the azo component. In 
these last reactions, non-electron-withdrawing group present in 
N-phenyl-DDs 1g,h favored the conventional attack to the α,β-
unsaturated ester moiety affording pyrrolidines or 
octahydroindolizine 5 and 7, respectively, unlike to the reactivity 
exhibited by EWG-DDs 1a-f in which an electron-withdrawing 
substituent is bound at the terminal nitrogen of the azo-ene 
system. The chemical behaviour of these different DDs can be 
explained according to their different LUMO-coefficients.[34] As 
depicted in Figure 1, the very large LUMO-coefficients of the 
EWG-DDs 1a located in α-carbon to the ester group and the 
nitrogen atom of the aza-moiety interact with large coefficients of 
fleeting azomethine ylide 2a (coefficients around 0.7 and -0.7 in 
the two carbon atoms). Note the most stable transoid 
conformation of DD 1a, at high temperature it must be converted 
in its corresponding cisoid one to complete the reaction. Again 
we can propose a concerted mechanism due the conservation of 
the relative configuration of the substituents of the DD. 
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Figure 1. LUMO orbital coefficients for 1a calculated at B3LYP/6-311+g(d,p) 
level of theory. 
In contrast, the LUMO-coefficients for N-phenyl-DDs 1g-h show 
very similar size. The value of α-carbon to the ester group is -0.5, 
and this is the main reactive centre; similarly, the contiguous 
carbon atom has a 0.40 value. As five membered rings are 
formed faster than seven membered ones, the [3+2] occurred 
preferentially rather than the [4+3] (Figure 2). We presumed that 
a step-wise process occur rather than a concerted one.  
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Figure 2. LUMO orbital coefficients for 1g calculated at B3LYP/6-311+g(d,p) 
level of theory for the two conformers. 
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Conclusions 
We have reported the first 1,3-DC between azomethine ylides 
and 1,2-diaza-1,3-dienes (DDs). Two main classes of products 
can be obtained: 1,2,4-triazepines, and pyrrolidines by means of 
[3+4] or [3+2] cycloadditions, respectively. We have 
demonstrated as the preference of the [3+4] cycloaddition is 
controlled by the presence in N-EWG-DDs 1a-f of an electron-
withdrawing group bound directly to the azo-moiety able to 
stabilize the anionic intermediate. On the contrary, under the 
same conditions the reactions of N-phenyl DDs lacking of 
electron withdrawing moiety on the nitrogen in position 1 of the 
azo-ene system gave the [3+2] cycloaddition product. 
Furthermore, the [3+2] cycloadditions show the same 
regioselectivity of the attack of the negative charge of the dipole 
displayed for the reactions involving nitrones,[20] but with the 
opposite trend in respect to the [3+4] cycloaddition.  
The normal endo-approach of DDs 1 was confirmed in the [3+2] 
processes finding two ester and methyl groups in a cis-
arrangement. Considering the operational simplicity and that the 
obtained products represent interesting scaffolds deployed with 
a variety of functional groups, a convenient and practical 
synthetic methodology has been developed.  
Experimental Section 
General information. All the commercially available reagents and 
solvents were used without further purification. 1,2-Diaza-1,3-dienes 1a-h 
were synthesized as a mixture of E/Z isomers as previously 
reported. 35  Sarcosine 2a, N-benzyl glycine ethyl ester 6a or ethyl 
pipecolinate 6b and paraformaldehyde 3a are commercial materials and 
were used without further purification. Chromatographic purification of 
compounds was carried out on silica gel (60–200 μm). TLC analysis was 
performed on pre-loaded (0.25 mm) glass supported silica gel plates 
(Kieselgel 60); compounds were visualized by exposure to UV light and 
by dipping the plates in 1% Ce(SO4)·4H2O, 2.5% (NH4)6Mo7O24·4H2O 
in 10% sulphuric acid followed by heating on a hot plate. All 1H NMR 
and 13C NMR spectra were recorded at 400 and 100.56 MHz, 
respectively. Proton and carbon spectra were referenced internally to 
solvent signals, using values of δ = 2.50 ppm for proton (middle peak) 
and δ = 39.50 ppm for carbon (middle peak) in DMSO-d6 and δ = 7.27 
ppm for proton and δ = 77.00 ppm for carbon (middle peak) in CDCl3. 
The following abbreviations are used to describe peak patterns where 
appropriate: s = singlet, d = doublet, t = triplet q = quartet, sex = sextet, m 
= multiplet and br = broad signal. All coupling constants (J) are given in 
Hz. FT-IR spectra were obtained as Nujol mulls. Mass spectra were 
recorded in the EI mode (70eV). Melting points were determined in open 
capillary tubes and are uncorrected. 
General procedure for the synthesis of 3,4,5,6-tetrahydro-2H-1,2,4-
triazepine-2,6-dicarboxylate 4a-f. DDs 1a-f (2.0 mmol), sarcosine 2a 
(90 mg, 1.0 mmol), and paraformaldehyde 3a (60 mg, 2.0 mmol) were 
dissolved in toluene (5 mL). The reactions were refluxed for 5.0-7.0 h. 
Then, the solvent was evaporated under reduced pressure and the crude 
mixture was chromatographed on silica gel (ethyl acetate : cyclohexane) 
obtaining pure 3,4,5,6-tetrahydro-2H-1,2,4-triazepine-2,6-dicarboxylates 
4a-f. 
 
2-Tert-butyl 6-methyl 4,7-dimethyl-3,4,5,6-tetrahydro-2H-1,2,4-
triazepine-2,6-dicarboxylate 4a: Pale yellow oil, 185 mg, 65%;IR νmax: 
1758, 1713 cm-1; 1H-NMR δ: 1.50 (s, 9H, C(CH3)3), 2.07 (s, 3H, CH3), 
2.42 (s, 3H, NCH3), 2.85 (dd, 1H, J = 13.2 Hz, J = 2.4 Hz, CHCH2NCH3), 
3.07 (dd, 1H, J = 13.2 Hz, J = 7.6 Hz, CHCH2NCH3), 3.73-3.79 (m, 1H, 
CHCH2NCH3), 3.75 (s, 3H), 4.23 (d, 1H, J = 14.0 Hz, NCH2N), 4.72 (d, 
1H, J = 14.0 Hz, NCH2N); 13C-NMR δ: 23.6 (q), 28.1 (q), 41.2 (q), 49.0 (t), 
51.7 (d), 52.4 (q), 69.6 (t), 81.6 (s), 158.9 (s), 170.9 (s), 174.8 (s); MS 
(EI) m/z (%): 285 (M+, 1%), 270 (3), 254 (2), 226 (2), 212 (7), 169 (10), 
153 (18), 110 (9); anal. calcd. for C13H23N3O4 (285.3395): C 54.72, H 
8.12, N 14.73; found: C 54.59, H 8.08, N 14.87. 
 
2-Tert-butyl 6-ethyl 4,7-dimethyl-3,4,5,6-tetrahydro-2H-1,2,4-
triazepine-2,6-dicarboxylate 4b: Pale yellow oil, 161 mg, 54%; IR νmax: 
1758, 1695 cm-1; 1H-NMR (CDCl3) δ: 1.28 (t, 3H, J = 7.2 Hz , OCH2CH3), 
1.50 (s, 9H, C(CH3)3), 2.08 (s, 3H, CH3), 2.42 (s, 3H, NCH3), 2.84 (dd, 
1H, J = 13.2 Hz, J = 2.4 Hz, CHCH2NCH3), 3.05 (dd, 1H, J = 13.2 Hz, J 
= 7.6 Hz, CHCH2NCH3), 3.75 (dd, 1H, J = 7.6 Hz, J = 2.0 Hz, 
CHCH2NCH3), 4.17-4.25 (m, 3H, OCH2CH3, NCH2N), 4.73 (d, 1H, J = 
14.0 Hz, NCH2N); 13C-NMR δ: 14.0 (q), 23.6 (q), 28.15 (q), 41.2 (q), 49.1 
(t), 51.8 (d), 61.4 (t), 69.8 (t), 81.4 (s), 154.4 (s), 159.1 (s), 170.4 (s); MS 
(EI) m/z (%): 299 (M+, 1%), 254 (7), 241 (30), 225 (18), 198 (28), 153 
(10), 125 (38); anal. calcd. for C14H25N3O4 (299.3661): C 56.17, H 8.42, 
N 14.04; found: C 56.29, H 8.45, N 13.92. 
 
2-Tert-butyl 6-methyl 7-ethyl-4-methyl-3,4,5,6-tetrahydro-2H-1,2,4-
triazepine-2,6-dicarboxylate 4c: Pale yellow oil, 117 mg, 39%; IR νmax: 
1748, 1697 cm-1; 1H-NMR δ: 1.14 (t, 3H, J = 7.6 Hz , CH2CH3), 1.50 (s, 
9H, C(CH3)3), 2.29-2.45 (m, 2H, CH2CH3), 2.39 (s, 3H, NCH3), 2.80 (dd, 
1H, J = 12.8 Hz, J = 2.4 Hz, CHCH2NCH3), 3.12 (dd, 1H, J = 12.8 Hz, J 
= 6.8 Hz, CHCH2NCH3), 3.72 (dd, 1H, J = 6.8 Hz, J = 2.4 Hz, 
CHCH2NCH3), 3.75 (s, 3H, OCH3), 4.34 (d, 1H, J = 14.0 Hz, NCH2N), 
4.57 (d, 1H, J = 14.0 Hz); 13C-NMR δ: 11.0 (q), 28.2 (q), 30.8 (t), 41.6 (q), 
48.6 (t), 52.3 (d), 52.5 (q), 69.6 (t), 81.3 (s), 154.4 (s), 162.4 (s), 171.0 
(s); MS (EI) m/z (%): 299 (M+, 2%), 268 (2), 226 (6), 198 (4), 183 (10), 
167 (17); anal. calcd. for C14H25N3O4 (299.3661): C 56.17, H 8.42, N 
14.04; found: C 56.06, H 8.39, N 14.27. 
 
2-Tert-butyl 6-methyl 4-methyl-7-propyl- 3,4,5,6-tetrahydro-2H-1,2,4-
triazepine-2,6-dicarboxylate 4d: Pale yellow oil, 100 mg, 32%; IR νmax: 
1750, 1704 cm-1; 1H-NMR δ: 0.93 (t, 3H, J = 7.2 Hz , CH2CH2CH3), 1.48 
(s, 9H, C(CH3)3), 1.59 (sex, 2H, CH2CH2CH3), 2.22-2.35 (m, 2H, 
CH2CH2CH3) 2.40 (s, 3H, NCH3), 2.77 (dd, 1H, J = 12.8 Hz, J = 2.4 Hz, 
CHCH2NCH3), 3.10 (dd, 1H, J = 12.8 Hz, J = 6.8 Hz, CHCH2NCH3), 
3.70 (dd, 1H, J = 6.8 Hz, J = 2.4 Hz, CHCH2NCH3), 3.73 (s, 3H, OCH3), 
4.32 (d, 1H, J = 14.0 Hz, NCH2N), 4.52 (d, 1H, J = 14.0 Hz, 
NCH2N); 13C-NMR δ: 14.1 (q), 21.0 (t), 28.2 (q), 39.4 (t), 41.4 (q), 48.7 (t), 
52.2 (q), 52.4 (d), 69.5 (t), 81.2 (s), 161.9 (s), 170.9 (s), 171.1 (s); MS 
(EI) m/z (%): 298 (2), 281 (3), 255 (4), 197 (21), 181 (18), 167 (31), 153 
(24); anal. calcd. for C15H27N3O4 (313.3927): C 57.49, H 8.68, N 13.41; 
found: C 57.38, H 8.66, N 13.52. 
 
Tert-butyl 6-[(dimethylamino)carbonyl]-4,7-dimethyl-3,4,5,6-
tetrahydro-2H-1,2,4-triazepine-2-dicarboxylate 4e: Pale yellow oil, 75 
mg, 25%;IR νmax: 1746, 1707 cm-1; 1H-NMR δ: 1.50 (s, 9H, C(CH3)3), 
2.02 (s, 3H, CH3), 2.45 (s, 3H, NCH3), 2.79-2.95 (m, 2H, CHCH2NCH3), 
2.97 (s, 3H, N(Me)2), 2.98 (s, 3H, N(Me)2), 3.86 (d, 1H, J = 13.6 Hz, 
NCH2N), 4.21 (dd, 1H, J = 9.2 Hz, J = 2.0 Hz, CHCH2NCH3), 4.87 (d, 1H, 
J = 13.6 Hz, NCH2N); 13C-NMR δ: 21.6 (q), 28.2 (q), 35.5 (q), 37.4 (q), 
40.4 (q), 44.4 (t), 51.7 (d), 69.6 (t), 81.4 (s), 154.5 (s), 166.0 (s), 170.1 
(s); MS (EI) m/z (%): 298 (M+ 2%), 241 (4), 225 (19), 197 (63), 153 (18), 
125 (78); anal. calcd. for C16H26N4O3 (298.3814): C 56.35, H 8.78, N 
18.78; found: C 56.49, H 8.83, N 18.66. 
 
2-Benzyl 6-ethyl 4,7-dimethyl-3,4,5,6-tetrahydro-2H-1,2,4-triazepine-
2,6-dicarboxylate 4f: Pale yellow oil, 117 mg, 39%; IR νmax: 1746, 1704 
cm-1; 1H-NMR δ: 1.28 (t, 3H, J = 7.2 Hz , OCH2CH3), 2.11 (s, 3H, CH3), 
2.44 (s, 3H, NCH3), 2.86 (dd, 1H, J = 13.2 Hz, J = 2.4 Hz, CHCH2NCH3), 
3.10 (dd, 1H, J = 13.2 Hz, J = 7.6 Hz, CHCH2NCH3), 3.79 (dd, 1H, J = 
7.6 Hz, J = 2.4 Hz, CHCH2NCH3), 4.18-4.23 (m, 2H, OCH2CH3), 4.31 (d, 
1H, J = 14.0 Hz), 4.81 (d, 1H, J = 14.0 Hz), 5.26 (s, 2H, OCH2Ph), 7.30-
7.42 (m, 5H, Ar); 13C-NMR δ: 14.0 (q), 23.7 (q), 41.2 (q), 49.2 (t), 51.7 (d), 
61.5 (t), 68.0 (t), 69.9 (t), 128.1 (d), 128.3 (d), 128.4 (d), 136.1 (s), 160.5 
(s), 166.5 (s), 170.2 (s); MS (EI) m/z (%): 287 (7), 260 (2), 167 (28), 149 
(100), 123 (50); anal. calcd. for C17H23N3O4 (333.3382): C 61.25, H 6.95, 
N 12.60; found: C 61.38, H 6.99, N 12.47. 
 
General procedure for the synthesis of 4-
[phenyldiazenyl]pyrrolidine-3-carboxylates 5a,b, 3-(2-
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phenyldiazenyl)pyrrolidine-2,4-dicarboxylates 7a,b, 1-
(phenyldiazenyl)hexahydroindolizine-2,8a(1H)-dicarboxylate 7c,d.  
Sarcosine 2a (90 mg, 1.0 mmol), or N-benzylglycine ethyl ester 6a (193 
mg, 1.0 mmol), or ethyl pipecolinate 6b (157 mg, 1.0 mmol), DDs 1g,h 
(2.0 mmol), and paraformaldehyde 3a (2.0 mmol) were dissolved in 
toluene (5 mL). The reactions were refluxed for 5.0-7.0. Then, the solvent 
was evaporated under reduced pressure and the crude mixture was 
chromatographed on silica gel (ethyl acetate : cyclohexane) obtaining 4-
[phenyldiazenyl]pyrrolidine-3-carboxylates 5a,b, 3-(2-
phenyldiazenyl)pyrrolidine-2,4-dicarboxylates 7a,b, 1-
(phenyldiazenyl)hexahydroindolizine-2,8a(1H)-dicarboxylate 7c,d. 
 
Methyl 1,4-dimethyl-4-[phenyldiazenyl]pyrrolidine-3-carboxylate 5a: 
Pale yellow oil, 157 mg, 60%; IR νmax: 1749 cm-1; 1H-NMR δ: 1.32 (s, 3H, 
CH3), 2.38 (s, 3H, NCH3 ), 2.52 (d, 1H, J = 10.0 Hz, CH2NCH3), 2.92 
(dd, 1H, J = 9.6 Hz, J = 8.4 Hz, CHCH2NCH3), 3.13 (dd, 1H, J = 8.8 Hz, 
J = 8.4 Hz, CHCH2NCH3), 3.41 (d, 1H, J = 10.0 Hz, CH2NCH3), 3.71 (s, 
3H, OCH3), 3.98 (t, 1H,  J = 8.4 Hz, CHCH2NCH3), 7.40-7.48 (m, 3H, Ar), 
7.74 (dd, 2H, J = 7.6 Hz, J = 1.2 Hz, Ar); 13C-NMR δ: 19.8 (q), 42.1 (q), 
49.5 (d), 51.6 (q), 58.1 (t), 66.6 (t), 79.7 (s), 122.5 (d), 128.8 (d), 130.6 
(d), 151.4 (s), 173.4 (s); MS (EI) m/z (%): 261 (M+ 2%), 183 (17), 169 
(43), 156 (45), 149 (100); anal. calcd. for C14H19N3O2 (261.3197): C 
64.35, H 7.33, N 16.08; found: C 64.46, H 7.36, N 15.97. 
 
Ethyl 1,4-dimethyl-4-[phenyldiazenyl]pyrrolidine-3-carboxylate 5b: 
Pale yellow oil, 107 mg, 39%; IR νmax: 1734 cm-1; 1H-NMR δ: 1.26 (t, 3H, 
J = 7.2 Hz, OCH2CH3), 1.34 (s, 3H, CH3), 2.38 (s, 3H, NCH3), 2.51 (d, 
1H, J = 10.0 Hz, CH2NCH3), 2.91 (dd, 1H, J = 9.2 Hz, J = 9.2 Hz, 
CHCH2NCH3), 3.13 (dd, 1H, J = 8.8 Hz, J = 8.8 Hz, CHCH2NCH3), 3.41 
(d, 1H, J = 10.0 Hz, CH2NCH3), 3.98 (t, 1H,  J = 8.4 Hz, CHCH2NCH3), 
4.13-4.20 (m, 2H, OCH2CH3), 7.40-7.48 (m, 3H, Ar), 7.73 (dd, 2H, J = 
8.4 Hz, J = 2.0 Hz, Ar); 13C-NMR δ: 14.3 (q), 19.8 (q), 42.2 (q), 49.7 (d), 
58.2 (t), 60.5 (t), 66.9 (t), 79.7 (s), 122.5 (d) , 128.8 (d), 130.5 (d), 151.5 
(s), 172.9 (s); MS (EI) m/z (%): 275 (M+ 5%), 260 (4), 231 (10), 183 (90), 
170 (100); anal. calcd. for C15H21N3O2 (275.3463): C 65.43, H 7.69, N 
15.26; found: C 65.31, H 7.65, N 15.36. 
 
2-Ethyl 4-methyl 1-benzyl-3-methyl-3-(2-phenyldiazenyl)pyrrolidine-
2,4-dicarboxylate 7a:36 mixture of diastereoisomers Pale yellow oil, 
205 mg, 50%; IR νmax: 1755 cm-1; 1H-NMR(dr  59:41, * denotes minor 
diasteoisomer signals) δ: 1.15* (t, 3H, J = 7.2 Hz, OCH2CH3), 1.19 (t, 3H, 
J = 7.2 Hz, OCH2CH3), 1.39 (s, 3H, CH3), 1.49* (s, 3H, CH3), 2.97 (t, 1H, 
J = 9.6 Hz, CHCO2Me), 3.02* (t, 1H, J = 9.6 Hz, CHCO2Me), 3.57* (s, 
2H, NCH2Ar), 3.63 (s, 3H, OCH3), 3.65* (s, 3H, OCH3), 3.63-3.73 (m, 2H, 
NCH2Ar), 3.89-3.96 (m, 1H, CH2N), 4.03-4.22 (m, 4H, OCH2CH3, CH2N, 
CHCO2Et), 7.26-7.39 (m, 5H, Ar), 7.44-7.52 (m, 3H, Ar), 7.68-7.74 (m, 
2H, Ar). 
 
2-Ethyl 4-methyl 1-benzyl-3-methyl-3-(2-phenyldiazenyl)pyrrolidine-
2,4-dicarboxylate 7a: one pure diastereoisomer IR νmax: 1755 cm-
1; 1H-NMR δ: 1.19 (t, 3H, J = 7.2 Hz, OCH2CH3), 1.38 (s, 3H, CH3), 2.96 
(t, 1H, J = 9.6 Hz, CHCO2Me), 3.63 (s, 3H, OCH3), 3.63-3.73 (m, 2H, 
NCH2Ar), 3.92 (dd, 1H, J = 9.2 Hz, J = 7.4 Hz CH2N), 4.03-4.23 (m, 4H, 
OCH2CH3, CH2N, CHCO2Et), 7.26-7.33 (m, 5H, Ar), 7.43-7.52 (m, 3H, 
Ar), 7.72 (dd, 2H, J = 8.0 Hz, J = 1.6.2 Hz, Ar); 13C-NMR δ: 14.2 (q), 16.0 
(q), 49.1 (t), 51.7 (d), 52.4 (q), 57.2 (t), 60.5 (t), 72.0 (d), 80.6 (s), 122.3 
(d) , 127.1 (s), 128.2 (d), 128.8 (d), 129.0 (d), 130.6 (d), 151.6 (s), 170.7 
(s), 171.6 (s); MS (EI) m/z (%): 303 (15), 244 (20), 231 (7), 217 (5), 123 
(34); anal. calcd. for C23H27N3O4 (409.4873): C 67.46, H 6.65, N 10.26; 
found: C 67.56, H 6.67, N 10.14. 
 
Diethyl 1-benzyl-3-methyl-3-(2-phenyldiazenyl)pyrrolidine-2,4-
dicarboxylate 7b:37 mixture of diastereoisomers Pale yellow oil, 123 
mg, 29%; IR νmax: 1742, 1752 cm-1; 1H-NMR(dr  65:35, * denotes minor 
diasteoisomer signals) δ: 1.15* (t, 3H, J = 7.2 Hz, OCH2CH3), 1.16 (t, 3H, 
J = 6.8 Hz, OCH2CH3), 1.18 (t, 3H, J = 7.2  Hz, OCH2CH3), 1.21* (t, 3H, 
J = 7.2 Hz, OCH2CH3), 1.40 (s, 3H, CH3), 1.50* (s, 3H, CH3), 2.96 (t, 1H, 
J = 10.0 Hz, CHCO2Me), 3.03* (t, 1H, J = 9.6 Hz, CHCO2Me), 3.63-3.72 
(m, 2H, NCH2Ar), 3.86-3.91 (m, 1H, CH2N), 4.02-4.22 (m, 6H, 2 
OCH2CH3, CH2N, CHCO2Et), 7.24-7.41 (m, 5H, Ar), 7.44-7.52 (m, 3H, 
Ar), 7.67-7.73 (m, 2H, Ar); 13C-NMR δ: 14.1 (q), 14.2 (q), 15.7 (q), 19.8 
(q), 48.2 (q), 49.5 (t), 52.3 (d), 53.1 (d), 57.4 (t), 57,6 (t), 60.4 (t),60.5 (t), 
60.6 (t), 72.1 (s), 75.0 (d), 80.4 (s), 122.2 (d) , 122.3 (d), 122.5 (d), 127.1 
(s), 127.2 (s), 128.1 (d), 128.2 (d), 128.8 (d), 128.8 (d), 128.9 (d), 129.2 
(d), 130.5 (d), 130.7 (d), 151.4 (s), 151.7 (s), 170.3 (s), 170.9 (s), 172.1 
(s)172.8 (s); MS (EI) m/z (%): 318 (4), 245 (5), 244 (16), 167 (17), 123 
(46); anal. calcd. for C24H29N3O4 (423.5049): C 68.06, H 6.90, N 9.92; 
found: C 67.95, H 6.87, N 10.03. 
 
8a-Ethyl 2-methyl 1-methyl-1-(phenyldiazenyl)hexahydroindolizine-
2,8a(1H)-dicarboxylate 7c: Pale yellow oil, 149 mg, 40%; IR νmax: 1754, 
1752 cm-1; 1H-NMR δ: 1.23 (t, 3H, J = 7.2 Hz, OCH2CH3), 1.30 (s, 3H, 
CH3), 1.58-1.81 (m, 4H, CH2CH2), 1.97-2.06 (m, 2H, CH2CH2),  2.91 
(dd, 1H, J = 13.6 Hz, J = 4.4 Hz,  NCH2CH2), 3.13 (dt, 1H, J = 13.2 Hz, J 
= 3.6 Hz, NCH2CH2), 3.36 (dd, 1H, J = 10.0 Hz,  J = 9.6 Hz, CHCO2Me), 
3.59 (s, 3H, CO2CH3), 3.81 (dd, 1H, J = 9.2 Hz,  J = 7.2 Hz, 
CH2CHCO2Me), 4.13-4.27 (m, 3H, OCH2CH3, CH2CHCO2Me), 7.43-
7.49 (m, 3H, Ar), 7.70 (dd, 2H, J = 8.0 Hz, J = 1.6 Hz, Ar); 13C-NMR δ: 
14.2 (q), 16.9 (q), 20.2 (t), 21.8 (t), 27.1 (t), 45.6 (t), 46.6 (d), 50.2 (t), 
51.5 (q), 60.6 (t), 75.9 (s), 81.1 (s), 122.4 (d) , 128.9 (d), 130.4 (d), 151.8 
(s), 172.1 (s), 172.3 (s); MS (EI) m/z (%): 300 (4), 195 (25), 164 (14), 136 
(40); anal. calcd. for C20H27N3O4 (373.4462): C 64.32, H 7.29, N 11.25; 
found: C 64.45, H 7.34, N 11.17. 
 
Diethyl 1-methyl-1-(phenyldiazenyl)hexahydroindolizine-2,8a(1H)-
dicarboxylate 7d: Pale yellow oil, 174 mg, 45%; IR νmax: 1743, 1736 cm-
1; 1H-NMR δ: 1.13 (t, 3H, J = 7.2 Hz, OCH2CH3), 1.20 (t, 3H, J = 7.2 Hz, 
OCH2CH3), 1.31 (s, 3H, CH3), 1.64-1.89 (m, 4H, CH2CH2), 2.08 (d, 1H, 
J = 13.2 Hz, CH2CH2),  2.92 (d, 1H, J = 10.8 Hz, CH2CH2), 3.17 (dt, 1H, 
J = 13.2 Hz, J = 3.2 Hz,  NCH2CH2), 3.37 (t, 1H, J = 10.0 Hz, 
NCH2CH2), 3.81-3.85 (m, 1H, CHCO2Et), 4.00-4.26 (m, 6H, 2 
OCH2CH3, CH2CHCO2Me), 7.42-7.50 (m, 3H, Ar), 7.69 (dd, 2H, J = 8.0 
Hz, J = 1.6 Hz, Ar); 13C-NMR δ: 14.1(q), 14.2 (q), 16.6 (q), 20.0 (t), 21.9 
(t), 27.2 (t), 45.7 (d), 46.8 (t), 50.0 (t),  60.5 (t), 60.7 (t), 76.1 (s), 81.0 (s), 
122.4 (d) , 128.9 (d), 130.4 (d), 152.0 (s), 171.7 (s), 172.2 (s); MS (EI) 
m/z (%): 315 (3), 314 (13), 287 (7), 209 (42), 179 (12), 164 (14), 136 
(82); anal. calcd. for C21H29N3O4 (387.4728): C 65.09, H 7.54, N 10.84; 
found: C 65.22, H 7.47, N 10.73. 
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